Send to

Choose Destination
J Antimicrob Chemother. 1994 May;33(5):925-35.

Extended-spectrum beta-lactamase in Proteus mirabilis.

Author information

Laboratoire de Microbiologie, Hôpital Ambroise Paré, Faculté de Médicine, Paris-Ouest, Boulogne, France.


Over a period of one month, five isolates of Proteus mirabilis resistant to extended-spectrum cephalosporins colonized or infected five patients of the same intensive care unit. The antibiotic resistance phenotype and the metabolic profiles of the five strains were identical. All five produced a plasmid-mediated extended-spectrum beta-lactamase closely related to TEM-3/CTX-1 according to its pI (6.3), to its substrate profile and to the hybridization of the corresponding gene with blaTEM-3 specific oligonucleotide probes. Ability to produce this enzyme transferred by conjugation to Escherichia coli along with aminoglycoside and sulphonamide resistance. These resistance markers were encoded by a plasmid, (pAP1) which was identical in all five isolates but which was different from the TEM-3 beta-lactamase plasmids found in other Enterobacteriaceae. Plasmid pAP1 differed by its smaller size (47 kb), its EcoRI restriction pattern, its resistance co-markers (AAC(6') and sulphonamide only) and its much lower transfer frequency (2 x 10(-8)). Furthermore this plasmid did not belong to any known Enterobacteriaceae incompatibility group.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center